Stallergenes Greer (Stallergenes Greer) Momentum Rank : 0 (As of May. 23, 2024)

View and export this data going back to 2013. Start your Free Trial

What is Stallergenes Greer Momentum Rank?

Stallergenes Greer has the Momentum Rank of 0.

For Momentum Rank, we considered the residual momentum concept that was widely studied by Blitz and his colleagues as well as by Nobel Prize laureates Fama and French. However, we did not find any significant differences in the performances of stocks with different ranks of residual momentum. Therefore, we use traditional momentum instead.

Momentum Rank is determined using the standardized momentum ratio and other momentum indicators. The standardized momentum ratio is the average of the performances from 12 months ago to 1 month ago and 6 months ago to 1 month ago, divided by the beta of the stock over the past 12 months. To calculate the momentum ratio today, we would use the average of the two performance numbers.

For momentum, we found that stock price performance does not have a monotonic correlation with the momentum ratio. The stocks with the highest momentum ratios perform worse than those at about the 70th percentile. Therefore, for the momentum rank, we ranked the stocks at about the 70th percentile of the momentum ratio as the highest at 10.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Stallergenes Greer Momentum Rank Related Terms

Thank you for viewing the detailed overview of Stallergenes Greer's Momentum Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Stallergenes Greer (Stallergenes Greer) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stallergenes Greer PLC (GREY:STLLF) » Definitions » Momentum Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

40 Bernard Street, 3rd Floor, London, GBR, WC1N 1LE

Website

http://www.stallergenesgreer.com

Stallergenes Greer PLC is a pharmaceutical company. The company treats severe allergic rhinitis with allergen immunotherapy. Its portfolio comprises of Sublingual products, Subcutaneous products, Veterinary products and Other. The sublingual products are offered under the brand name Staloral and Oralair. The Subcutaneous products include Phostal, Alustal, Alyostal, Albey. The company also offers enzyme-linked immunosorbent assay components and prescription services. It provides skin testing devices enabling the identification of the allergen or allergens responsible for the allergy, sterile diluents and sterile empty vials, syringes, and other compendial products. The company operates in internationally and geographically generates maximum revenue from the United States.

Stallergenes Greer (Stallergenes Greer) Headlines

No Headlines